Literature DB >> 18512753

Variations in gender ratios support the connection between smoking and Parkinson's disease.

Natalia Morozova1, Eilis J O'Reilly, Alberto Ascherio.   

Abstract

Smokers have a decreased risk of Parkinson's disease (PD), but this association could simply be the result of a common factor causing both PD and aversion to smoking. Smoking behavior in industrialized nations has changed dramatically over the second half of the 20th century, with diverging patterns in male and female smoking rates. We therefore examined whether PD incidence changed concomitantly, as would be expected if smoking truly reduced PD risk. We performed a PUBMED search to identify relevant studies reporting male and female age-specific prevalence or incidence of PD in different countries. For each country and birth cohort we then estimated the male to female ratio in PD incidence, and correlated these ratios with the corresponding male to female ratios in smoking behavior obtained from national statistics. We show that the relative frequency of PD among women declines when the proportion of women smoking increases. The strength of this correlation (r = 0.28; P = 0.0002) is comparable to the opposite trend observed for lung cancer, and supports an overall 74% reduction in risk of PD among smokers. Our results are consistent with the hypothesis that smoking reduces the risk of PD. Copyright 2008 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512753     DOI: 10.1002/mds.22045

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  Focus on α4β2* and α6β2* nAChRs for Parkinson's Disease Therapeutics.

Authors:  Xiomara A Pérez; Maryka Quik
Journal:  Mol Cell Pharmacol       Date:  2011

3.  Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.

Authors:  Alexander Rossi; Kristin Berger; Honglei Chen; Douglas Leslie; Richard B Mailman; Xuemei Huang
Journal:  Mov Disord       Date:  2017-06-07       Impact factor: 10.338

4.  Reply to: Diabetes and risk of Parkinson's disease.

Authors:  Natalia Palacios; Alberto Ascherio
Journal:  Mov Disord       Date:  2013-02       Impact factor: 10.338

5.  Time Trends in the Incidence of Parkinson Disease.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

6.  Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.

Authors:  Natalia Palacios; Alvaro Alonso; Henrik Brønnum-Hansen; Alberto Ascherio
Journal:  Ann Epidemiol       Date:  2011-05-07       Impact factor: 3.797

7.  Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women.

Authors:  Natalia Palacios; Xiang Gao; Eilis O'Reilly; Michael Schwarzschild; Marjorie L McCullough; Tinisha Mayo; Susan M Gapstur; Alberto A Ascherio
Journal:  Mov Disord       Date:  2012-06-19       Impact factor: 10.338

8.  Smoking duration, intensity, and risk of Parkinson disease.

Authors:  H Chen; X Huang; X Guo; R B Mailman; Y Park; F Kamel; D M Umbach; Q Xu; A Hollenbeck; A Schatzkin; A Blair
Journal:  Neurology       Date:  2010-03-10       Impact factor: 9.910

9.  Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.

Authors:  Kenneth D Cronin; Dongliang Ge; Paul Manninger; Colton Linnertz; Anna Rossoshek; Bonnie M Orrison; David J Bernard; Omar M A El-Agnaf; Michael G Schlossmacher; Robert L Nussbaum; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2009-06-04       Impact factor: 6.150

10.  Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality.

Authors:  Eilis J O'Reilly; Honglei Chen; Hannah Gardener; Xiang Gao; Michael A Schwarzschild; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2009-01-08       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.